Blueprint Medicines Corp (NASDAQ:BPMC)

92.22
Delayed Data
As of 4:00pm ET
 -3.39 / -3.55%
Today’s Change
43.29
Today|||52-Week Range
125.61
-17.77%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$5.6B

Company Description

Blueprint Medicines Corp. is a precision therapy company. It focuses on medicines to improve the lives of patients with genomically defined cancers, rare diseases and cancer immunotherapy. The company was founded by Chris Varma, Nicholas B. Lydon, Brian Druker, and Alexis Borisy on October 14, 2008 and is headquartered in Cambridge, MA.

Contact Information

Blueprint Medicines Corp.
45 Sidney Street
Cambridge Massachusetts 02139
P:(617) 374-7580
Investor Relations:
(617) 714-6674

Employees

Shareholders

Mutual fund holders58.98%
Other institutional45.00%
Individual stakeholders10.63%

Top Executives

Jeffrey W. AlbersPresident, Chief Executive Officer & Director
Kathryn HavilandChief Operating Officer
Michael LandsittelChief Financial Officer
Becker HewesChief Medical Officer
Fouad NamouniPresident-Research & Development